Botryococcene biosynthesis is thought to resemble that of squalene, a metabolite essential for sterol metabolism in all eukaryotes. Squalene arises from an initial condensation of two molecules of farnesyl diphosphate (FPP) to form presqualene diphosphate (PSPP), which then undergoes a reductive rearrangement to form squalene. In principle, botryococcene could arise from an alternative rearrangement of the presqualene intermediate. Because of these proposed similarities, we predicted that a botryococcene synthase would resemble squalene synthase and hence isolated squalene synthase-like genes from Botryococcus braunii race B. While B. braunii does harbor at least one typical squalene synthase, none of the other three squalene synthase-like (SSL) genes encodes for botryococcene biosynthesis directly. SSL-1 catalyzes the biosynthesis of PSPP and SSL-2 the biosynthesis of bisfarnesyl ether, while SSL-3 does not appear able to directly utilize FPP as a substrate. However, when combinations of the synthase-like enzymes were mixed together, in vivo and in vitro, robust botryococcene (SSL-1+SSL-3) or squalene biosynthesis (SSL1+SSL-2) was observed. These findings were unexpected because squalene synthase, an ancient and likely progenitor to the other Botryococcus triterpene synthases, catalyzes a two-step reaction within a single enzyme unit without intermediate release, yet in B. braunii, these activities appear to have separated and evolved interdependently for specialized triterpene oil production greater than 500 MYA. Coexpression of the SSL-1 and SSL-3 genes in different configurations, as independent genes, as gene fusions, or targeted to intracellular membranes, also demonstrate the potential for engineering even greater efficiencies of botryococcene biosynthesis.
B
otryococcus braunii is a colony-forming, freshwater green algae reported to accumulate 30-86% of its dry weight as hydrocarbon oils (1) . Three distinct races of B. braunii have been described based on the types of hydrocarbons that each accumulates (2) . Race A accumulates fatty acid-derived alkadienes and alkatrienes (3) , race L accumulates the tetraterpene lycopadiene (4) , and race B accumulates triterpenes, predominately botryococcene, squalene, and their methylated derivatives (5) . The oils accumulate both in intracellular oil bodies and in association with an extracellular matrix (6) , which in race B consists largely of long-chain, cross-linked biopolymers formed in part from acetalization of polymethylsqualene diols (7) . Di-and tetra-methylated botryococcenes are generally the most abundant triterpenes accumulating in race B with smaller amounts of tetramethylatedsqualene (8) and other structural derivatives of squalene and botryococcene that range from C 31 to C 37 accumulating to various levels in different strains and in response to variable culture conditions (9) . Other polymethylated derivatives such as diepoxytetramethylsqualene (10), botryolins (11) , and brauixanthins (12) have also been reported.
B. braunii race B has received significant attention because it is considered an ancient algal species dating back at least 500 MYA and is one of the few organisms known to have directly contributed to the existing oil and coal shale deposits found on Earth (13) (14) (15) , accounting for up to 1.4% of the total hydrocarbon content in oil shales (16) . Secondly, because the hydrocarbon oils of B. braunii race B are readily converted to starting materials for industrial chemical manufacturing and high quality fuels under standard hydrocracking/distillation conditions in yields approaching 97% (Fig. 1A ) (17) , race B has been considered a potential production host for renewable petrochemicals and biofuels. However, the slow growth habit of B. braunii poses serious limitations to its suitability as a robust biofuel production system. Capture of the genes coding for this unique oil biosynthetic capacity would therefore provide opportunities to engineer this metabolism into other faster growing and potentially higher yielding organisms (18) .
Our approach for identifying the triterpene biosynthetic genes in B. braunii has relied in large part on the putative similarities in the biosynthetic mechanisms for squalene and botryococcene (19) (20) (21) . Squalene biosynthesis has been extensively investigated because it is positioned at a putative branch point in the isoprenoid biosynthetic pathway directing carbon flux to sterol metabolism, and thus represents a potential control point for cholesterol biosynthesis in man (22) . Evidence for a two-step reaction mechanism catalyzed by squalene synthase has been described (23) (Fig. 1B) . The initial reaction step consists of a head-to-head condensation of two farnesyl diphosphate (FPP) molecules to form a stable cyclopropyl intermediate, presqualene diphosphate (PSPP) (24, 25) . In the second reaction step, PSPP undergoes a reductive rearrangement in the presence of NADPH to yield squalene possessing a C1-C1′ linkage between the two farnesyl substituents (26, 27) (Fig. 1B) . Poulter (23) also suggested that botryococcene biosynthesis could occur via an analogous reaction mechanism with the initial reaction proceeding through PSPP, followed by a reductive rearrangement yielding a C3-C1′ linkage between the two farnesyl precursors and possessing an ethyl as well as a methyl group at C3 in the final product.
Extensive investigations of squalene synthase including sitedirect mutagenesis (28) and structural elucidation of 3-dimensional structure (29) have focused on five highly conserved domains (domains I-V) thought associated with catalysis (30) . Many studies have also utilized these highly conserved domains as a means for isolating the corresponding genes from a diverse range of organisms. For instance, we previously described the functional characterization of a squalene synthase gene from B. braunii race B (31) . In that work, degenerate oligonucleotide primers complementary to several of the conserved domains were used to amplify a small region of a putative squalene synthase gene, and that gene fragment was then used to isolate a fulllength cDNA from a cDNA library. Heterologous expression of that cDNA in bacteria and in vitro characterization of the encoded enzyme validated that the cDNA encoded for a squalene synthase enzyme but lacked any detectable botryococcene synthase activity.
The current results represent our additional efforts to define the botryococcene biosynthetic pathway, to capture the genes coding for these unique enzymological transformations, and to reconstruct the initial steps of these unusual triterpene pathways in a heterologous host.
Results
Functional Identification of Genes for Triterpene Biosynthesis. Because we surmised that a botryococcene synthase enzyme might possess amino acid domains in common with squalene synthase, the B. braunii squalene synthase cDNA was used to rescreen the B. braunii cDNA library under low stringency hybridization conditions, and a unique squalene synthase-like gene (SSL-1) was isolated and characterized. The SSL-1 gene predicted a squalene synthase-like protein exhibiting some resemblance to other squalene synthase enzymes within domains I-V, but missing a carboxyterminal, membrane spanning domain (Fig. S1) . Surprisingly, purified bacterial-expressed SSL-1 protein did not exhibit either squalene nor botryococcene biosynthesis when assayed in vitro even in the presence of a variety of reducing cofactors like NADPH (Figs. S2A and S3) , ferredoxin, or cytochrome B5 systems. However, when SSL-1 was expressed in a yeast engineered for high-level production of FPP and having its endogenous squalene synthase and squalene epoxidase genes inactivated, presqualene alcohol (PSOH), the dephosphorylated form of PSPP, accumulated to significant levels (Fig. 2B) . Subsequent incubations of SSL-1 with radiolabeled FPP confirmed robust in vitro production of PSPP as the sole reaction product with a K m for FPP of 12.8 μM and catalytic turnover rate (k cat ) equal to 2.7 × 10 −2 ∕ sec with no stimulation of activity by NADPH addition (Fig. 2J and Fig. S3 ). This suggested that SSL-1 was catalytically competent for the first half reaction of squalene synthase but perhaps required additional conditions or algal factors for complete catalytic activity. Mixing the purified SSL-1 enzyme with algal cell-free lysate did indeed enhance NAD(P)H-dependent botryococcene biosynthesis up to 10-fold, which was also proportional to the amount of the purified SSL-1 protein or the algal lysate added (Fig. S2 A-C) . The mechanism for botryococcene biosynthesis thus appeared to be similar to squalene synthase in its first half reaction, catalysis of PSPP formation, but differed in requiring another algal cofactor that either shuttled reducing equivalents to the reaction mechanism of SSL-1 or participated directly in the conversion of PSPP to botryococcene.
Because no natural occurring squalene synthase catalyzing only the first or second half reactions has been reported, we reasoned that other squalene synthase-like cDNAs for botryococcene biosynthesis might exist and therefore undertook a more exhaustive assessment of the SSL genes expressed in the Botryococcus braunii race B cells. The transcriptomic data from two independent sequencing efforts were thus assembled together and screened computationally for additional squalene synthase-like genes. Two additional SSL genes were uncovered and labeled SSL-2 and SSL-3 (Fig. S1 ). Although both of the predicted proteins showed amino acid sequence similarity to other squalene synthases in excess of 62%, neither bacterial-expressed, purified enzymes exhibited any botryococcene biosynthesis and only SSL-2 showed a low capacity for squalene biosynthesis when incubated with FPP as substrate (Fig. 2G ). When expressed in yeast, SSL-3 also did not cause the accumulation of any distinct products (Fig. 2D ), but SSL-2 resulted in the accumulation of a small amount of squalene (approximately 10% of the total) and a terpene compound of unknown structure (Fig. 2C) . The dominant terpene accumulating in the SSL-2 expressing yeast was subsequently identified by NMR as bisfarnesyl ether and confirmed by comparative analysis of corresponding ether prepared by chemical synthesis (Fig. S4 ). Subsequent analysis of the reaction products generated by in vitro incubation of SSL-2 with FPP also verified this enzyme as the source of this unique terpene ether ( Fig. 2 G and J) .
The observations of unique terpene products from squalene synthase-like enzymes in Botryococcus, namely PSPP by SSL-1 and bisfarnesyl ether by SSL-2, suggested that triterpene metabolism in this algae may operate differently from that in other organisms. Hence, we considered the possibility that multiple SSL proteins might be required to give botryococcene biosynthesis. To evaluate this possibility, the different SSL genes were coexpressed in yeast, or the heterologous expressed and purified proteins were incubated in various combinations. When SSL-1 was coexpressed with SSL-2, the amount of squalene accumulat- ing increased about 30-fold ( Fig. 2E ) along with a significant accumulation of bisfarnesyl ether still occurring. When purified SSL-1 and SSL-2 enzymes were incubated in a 1∶1 stoichiometric ratio, squalene accumulation predominated (Fig. 2H) , suggesting that something different mechanistically might be occurring when the SSL-1 and 2 genes were coexpressed in yeast (see below). More surprising, however, when SSL-1 and SSL-3 were coexpressed, botryococcene accumulation became readily apparent and accumulated to upwards of 20 mg∕L along with 0.7 mg∕L of squalene (Fig. 2F) . In vitro incubations of the purified SSL-1 and SSL-3 proteins confirmed botryococcene as the predominant reaction product with squalene representing only 3-4% of the total reaction products ( Fig. 2 I and J) . Additional in vitro studies have also confirmed that both SSL-2 and SSL-3 are able to efficiently catalyze the biosynthesis of squalene and botryococcene, respectively, from PSPP but not FPP, and these activities of SSL-2 and SSL-3 are sufficient to account for all the squalene and botryococcene biosynthesized in combined assays with SSL-1 (Fig. S5 ). (Fig. 3) . Support for such a mechanism comes from the incorporation of radiolabeled FOH directly into the bisfarnesyl ether product, but only when SSL-2 is incubated with both FOH and FPP (Table 1) . To determine if the mechanism of NADPH dependence for bisfarnesyl ether formation by SSL-2 was catalytic or structural, the quantitative yield of reaction product and NADPH oxidation were determined. While the biosynthesis of 1,072 pmoles of squalene was correlated with an equal stoichiometric oxidation of 1,098 pmoles of NADPH by the Nicotiana benthamiana squalene synthase enzyme, greater than 21 pmoles of bisfarnesyl ether were formed by SSL-2 when only 4.6 pmoles of NADPH were oxidized (Table S1 ). Approximately half of the NADPH oxidation by SSL-2 under these conditions could be associated with the biosynthesis of 2.2 pmoles of squalene (Table S1) . Hence, about 10 times more bisfarnesyl ether is formed per mole equivalent 
Purified SSL-2 protein (2 μg) was incubated with either 10 μM 1 − 3 H − farnesol, 10 μM 1 − 3 H − farnesol plus 10 μM FPP, or 10 μM 1-3H-FPP in a 50-μl reaction at 37°C for 1 h, the reaction products extracted with MTBE, and aliquots separated on silica TLC plates. The radioactivity incorporated in the zones corresponding to bisfarnesyl ether were determined by scintillation counting. Data represents mean ± SEM.
of NADPH oxidation (21 pmoles versus 2.4 pmoles), more consistent with an allosteric or structural role for NADPH in the SSL-2 bisfarnesyl ether reaction rather than a catalytic one. A similar role for NADPH in stimulating PSPP formation by squalene synthases was reported earlier (29, 33, 34) .
Improving the Efficiency of Botryococcene Biosynthesis. Production of botryococcene by yeast was improved by engineering different configurations of the SSL-1 and SSL-3 genes (Fig. 4) . While coexpression of SSL-1 and SSL-3 yielded significant botryococcene, peptide fusions of SSL-1 and SSL-3 connected by a triplet repeat linker of GGSG improved production capacity greater than twofold to upwards of 50 mg∕L. Further enhancement to over 70 mg∕L was observed by appending the carboxy-terminal 63 or 71 amino acids of the Botryococcus squalene synthase onto the carboxy-termini of SSL-1 and SSL-3 enzymes, respectively. These terminal amino acids serve to tether squalene synthase, and by inference SSL-1 and 3, to the yeast's endo-membrane system, which might bring the enzymes in closer proximity to one another or give the enzymes greater access to endogenous FPP pools. Further support for this notion has been the observation of greater than 100 mg∕L of botryococcene by yeast overexpressing gene fusions of SSL-1 and SSL-3 harboring the putative ER membrane targeting sequence of the botryococcus squalene synthase.
Discussion
The results presented here were unexpected because squalene biosynthesis is known as a two-step process catalyzed by a single enzyme (Fig. 5) . FPP is first converted to the intermediate PSPP, followed by its reductive rearrangement to squalene (24) . However, PSPP is not evident in these reactions unless NADPH, the reducing reagent, is omitted from the incubations (19) . Under conditions of adequate NADPH, it appears unlikely that PSPP is released from the squalene synthase enzyme, then rebound as a natural consequence of the catalytic cycle (34) . Regardless, a single enzyme is responsible for the entire conversion process and this mechanism appears highly conserved from yeast to man, including algae like Botryococcus (31). In contrast, botryococcene biosynthesis appears to require the successive action of two distinct enzymes. First SSL-1 catalyzes the biosynthesis of PSPP as a separate and distinct product, which the second enzyme, SSL-3, efficiently converts to botryococcene in a NADPH-dependent manner. Whatever the evolutionary forces driving this division of labor might have been, it also appears to have occurred twice within the life history of Botryococcus. When SSL-1 is coexpressed with SSL-2, squalene accumulates, which we speculate might represent a distinct pool of squalene in Botryococcus destined to specialized roles like the biogenesis of the extracellular matrix and other squalene derivatives.
Support for the neofunctionalization of these unusual binary systems for triterpene biosynthesis is provided by the distinctive biosynthetic activities associated with SSL-2 (Fig. 5) . First, this enzyme catalyzes the NADPH-dependent biosynthesis of an unusual terpene ether. There are no reports of bisfarnesyl ether accumulation in Botryococcus or any other organism, but it could be incorporated into other more complex matrix polymers masking its detection. One possible means for bisfarnesyl ether biosynthesis does not involve a PSPP intermediate but instead an alternative reactivity of two bound farnesyl moieties via a S N 2 Williamson ether synthesis-type reaction (Fig. 3) (32) . Support for such a mechanism comes from the incorporation of radiolabeled FOH directly into the bisfarnesyl ether product, but only when SSL-2 is incubated with both FOH and FPP (Table 1) . Second, the accumulation of both squalene and bisfarnesyl ether in yeast coexpressing SSL-1 and SSL-2 is also consistent with this proposed mechanism. The yeast line used for these studies is engineered for high FPP production but tends to accumulate FOH as a consequence of FPP dephosphorylation catalyzed by endogenous phosphatases (35, 36) . Hence, the yeast coexpressing SSL-1 and SSL-2 have significant pools of FOH and FPP, which will compete with any PSPP generated by SSL-1 for binding and catalysis by SSL-2. Third, while there is no obvious or direct chemical requirement for reducing equivalents in the biosynthesis of the bisfarnesyl ether from FPP and FOH, the significance of the NADPH dependence might relate to a structural role rather than a catalytic one. Pandit et al. (29) suggested that NADPH binding to its putative bind site in the human squalene synthase might stabilize a region of the enzyme not well resolved in the crystal structure, and thus positioning a domain into close association with the active site. NADPH binding to the SSL-2 enzyme could evoke a similar conformational change that renders the SSL-2 enzyme competent for either bisfarnesyl ether or squalene biosynthesis dependent on available substrates (FPP, FOH, and PSPP). Hence, not only has SSL-2 maintained its catalytic ability to convert PSPP to squalene, it has evolved a novel catalytic activity yielding a bisprenyl ether from prenyl diphosphates. One possibility for how these unique triterpene synthases arose is that a progenitor squalene synthase gene could have duplicated to yield multiple gene copies. While one copy (BSS) maintained its coding capacity for squalene synthase activity, essential for sterol metabolism, the other copies (SSL-1, SSL-2, and SSL-3) would have afforded opportunities for evolutionary diversification. Alternatively, Botryococcus could have acquired multiple copies of SSL genes by a horizontal gene transfer process and those genes may have evolved specialized synthase-like activities. For example, one of the acquired squalene synthase-like genes could have evolved the capacity for botryococcene biosynthesis and a subsequent gene duplication event could have resulted in loss of function for either the first half reaction or the second. No matter the specific mechanism, what makes the possible events associated with the neofunctionalization of the SSL enzymes particularly intriguing is that specialized triterpene oil accumulation, like botryococcene, could not have occurred without both SSL-1 and SSL-3 evolving in concert with one another.
There are other examples of similar division and diversification of enzymological capacities within key genes for pyrimidine (37) , diterpene (38) , and triterpene (39) metabolism. For instance, biosynthesis of the diterpene kaurene in many fungi relies on a single, multifunctional enzyme (40) that catalyzes the conversion of the linear isoprenoid intermediate geranylgeranyl diphosphate to the bicyclic copalyl diphosphate (CPP) product. CPP then undergoes a second cyclization reaction initiated at a separate binding site on the same enzyme to yield kaurene. In higher plants, the enzymes for CPP and kaurene biosynthesis are encoded by separate and distinct genes (38) . Specific CPP synthases within rice catalyze the biosynthesis of either ent-CPP or syn-CPP isomers (41, 42) . These are complemented with equally distinct diterpene synthases that can utilize one or the other CPP isomer for hormone or defense compound biosynthesis (43, 44) . Yet, there are other diterpene synthases that have retained these two enzyme functions but have evolved whole new catalytic outcomes (45) . Osbourn and coworkers (39, 46) have also provided evidence that the genes encoding for the enzymes catalyzing the cyclization of oxidosqualene to distinct tetra-and penta-cyclic classes of triterpenes, primarily sterols and defense related saponins, respectively, likely arose from common ancestor genes evolving novel catalytic functions dedicated to primary and specialized metabolism. Microbial forms of dihydrosqualene synthase, like CrtM, might also be considered an example of squalene synthase-like enzyme diversification (47, 48) . CrtM relies on PSPP biosynthesis but does not utilize NADPH for the second half reaction. CrtM instead yields dehydrosqualene, a reaction product with much in common with phytoene, the tetraterpene equivalent of dehydrosqualene, and by inference shares catalytic features of the second half reaction in common with phytoene synthase. Nonetheless, what distinguishes the current results from all the others is there are no other known examples where the half-reaction specificity of squalene synthases appear separated from one another and subject to evolutionary diversification, except for that reported here for Botryococcus.
The family of squalene synthase-like enzymes in Botryococcus is also informative relative to the recent elucidation of the crystal structure of dehydrosqualene synthase (CrtM) of Staphylococcus aureus, a target enzyme for a new generation of antiinfective reagents, along with refinements in the human squalene synthase structure (47, 48) . Those studies detailed how two FPP molecules bind to CrtM and human squalene synthase, are converted to the PSPP intermediate, and then repositioned in the active site pocket in preparation for the second half reaction. Key residues identified include those that coordinate magnesium ions for their interactions with the diphosphate substituents of the FPPs and PSPP, and hence considered involved in both half-reactions. Based on sequence alignments (Fig. S1 ), many of these residues (S19, Y41, R45, D48, D52, Y129, N168, and D177, numbering according to CrtM and annotated by a star above the residue in Fig. S1 ) appear conserved in the Botryococcus squalene synthase and all three of the SSL enzymes. Because SSL-2 and SSL-3 are deficient in PSPP biosynthesis, these particular residues are not by themselves sufficient for PSPP biosynthesis. Conversely, since SSL-1 can only catalyze the formation of PSPP, these same residues do not appear sufficient to initiate the second half reaction. Amino acids at other positions are undoubtedly important for PSPP formation and the catalytic specificity of the second half reaction, squalene versus botryococcene biosynthesis. Experiments to functionally define which amino acids at which positions are responsible for the enzymological specificity of these triterpene synthases will be significantly advantaged by having these unique Botryococcus SSL enzymes, which are specialized to either the first half reaction or the second.
Altogether, our results establish that botryococcene and squalene oils are synthesized in Botryococcus braunii race B by (31) is thought to provide squalene essential for sterol metabolism, whereas the squalene synthase-like genes SSL-1, SSL-2, and SSL-3 provide for the triterpene oils serving specialized functions for the algae. In combination with SSL-1, SSL-2 could provide squalene for extracellular matrix and methylated squalene derivatives, while SSL-1 plus SSL-3 generates botryococcene, which along with its methyl derivatives, accounts for the majority of the triterpene oil.
the combined action of separate and distinct squalene synthaselike enzymes, have opened up new avenues for understanding the chemical specificity and diversification within this class of enzymes and provide a demonstration for the bioengineering and production of a key petrochemical replacement.
Methods
The squalene synthase-like cDNAs were isolated either by screening a Botryococcus cDNA library using low stringency hybridization conditions with a radiolabeled Botryococcus squalene synthase probe (yielding SSL-1), or by computational screening of the combined Botryococcus transcriptomic datasets with the Botryococcus squalene synthase cDNA sequence (yielding SSL-2 and SSL-3). These three genes were inserted into the pET28a vector for bacterial expression and the YEp352 or pESC vectors for yeast expression. Bacterial-expressed enzymes were purified, incubated with FPP or [1-3 H] FPP, and hexane extracts analyzed either by GC-MS, or by scintillation counting of the indicated products isolated by TLC, respectively. Various combinations of the SSL genes were transformed into the TN7 yeast line, the transformants grown in either YPDE or SCE media, and organic extracts of the cultures analyzed by GC-MS. TN7 was created by insertional mutagenesis of the ERG1 gene in the Cali-7 yeast line. The unknown terpene accumulating in TN7 expressing SSL-2 was purified by silica-HPLC, then subjected to standard NMR analyses along with chemically synthesized bisfarnesyl ether. Full details are given in SI Methods. Culturing of B. braunii. Botryococcus braunii Berkeley (Showa) strain was grown as previously described (1) , except that cultures were aerated with filter sterilized air containing 2.5% CO 2 . Algal cells were collected by vacuum filtration using a 20 μM nylon mesh, then scrapped into collection tubes, snap frozen in liquid N 2 and stored at −80°C until further use.
Cloning SSL-1. Plaque lifts of a B. braunii cDNA library previously described by Okada et al. (2) were prepared and hybridized with the full-length B. braunii squalene synthase cDNA radiolabeled with [α-
32 P]dCTP using a Prime-It kit (Stratagene). Hybridization was performed at 30°C in hybridization buffer consisting of 5X SSPE, 2X Denhardt's solution, 0.2% SDS, 100 μg mL −1 salmon sperm DNA and 40% formamide (2) . The plaque lifts were washed three times at room temperature for 5 min with 2X SSC, 0.1% SDS and hybridization detected by autoradiography. After two rounds of plaque purification, isolated plaques were converted to their plasmid forms according to the manufacturer's instructions (Stratagene), restriction digestions of the isolated plasmids compared, and only those showing distinctive differences to that for the Botryococcus squalene synthase examined further by automated DNA sequencing. DNA sequence of the squalene synthase-like (SSL-1) cDNA clone yielded a putative full-length open reading frame (ORF) coding for a 402 amino acid protein having a predicted molecular size of 45,692 daltons.
SSL-1 was cloned into the pET28a vector via the cloning site BamHI/XhoI in order to generate a SSL-1 protein with an aminoterminal hexa-histidine extension to aid in purification. The SSL-1 gene was also inserted into two standard yeast expression vectors, YEp352 harboring an ADH1 promoter and Ura3 selection via the cloning site EcoRI/HindIII, and pESC harboring an AHD1 promoter and Leu2 selection via the cloning site Bam-HI/NotI (3).
Cloning SSL-2. Transcriptomic sequencing was performed using RNA pooled from B. braunii cultures ranging from 1-4 weeks after subculturing. cDNA samples were prepared for de novo transcriptome sequencing similar to the protocol of Meyer et al. (4) , and the resulting cDNA samples processed for DNA sequencing according to the emPCR Method Manual (Roche). Sequencing was performed on a Roche Genome Sequencer FLX and the data assembled using Newbler (Roche). The assembled DNA sequence data was computationally screened using the NCBI blast search function with the Botryococcus squalene synthase cDNA sequence as the query, which revealed a partial ORF with strong similarity to the amino-terminal halves of BSS and SSL-1. To determine the full-length sequence for this SSlike gene (termed SSL-2), an aliquot of plasmid DNA derived from the phage cDNA library described above (using the mass excision protocol as described by Stratagene) was used in PCR reactions with primers specific to SSL-2 and primers specific to the pBluescript SK-vector in attempt to amplify the missing 3′ sequence of SSL-2. An 800 bp band was isolated, ligated into the pGEM T-Easy vector (Promega), and sequenced. This sequence information was used to deduce the full-length sequence for SSL-2, which encodes for a predicted protein consisting of 465 amino acids and having a molecular size of 52,149 daltons.
The full-length SSL-2 cDNA was cloned into the Yep352 yeast expression vector via the cloning site EcoRI/NotI. Because SSL-2 encodes for a protein with at least one predicted membrane spanning region at its C terminus, we designed a truncated form of SSL-2 in which 73 C-terminal amino acids were deleted (SSL-2-tr2). SSL-2-tr2 was cloned into the pET28a vector via the cloning site EcoRI/NotI.
Cloning SSL-3. The DNA sequence data obtained from a second transcriptomic profiling effort (www.jgi.doe.gov/sequencing/ why/bbraunii.html) was combined with the first, and the combined dataset assembled with CLC Genomics Workbench (CLC Bio). Screening of this dataset with the Botryococcus squalene synthase revealed another ORF encoding a 383 amino acid squalene synthase-like (SSL-3) protein with a predicted molecular size of 44,127 daltons. SSL-3 was cloned into the pET28a and Yep352 vectors via the cloning sites EcoRI/NotI.
Protein Expression, Purification, and Enzyme Assays. The recombinant vectors were transformed into E. coli strain BL21(DE3) according to the manufacturer's recommendations (Novagen). The selected lines were grown with kanamycin selection at 37°C with vigorous shaking until the cultures reached an optical density of approximately 0.8 (OD 600 nm), then expression of the corresponding SSL gene induced by addition of 0.5 mM isopropylthio-β-D-galactoside (IPTG) and the cultures incubate for an additional 3 to 20 h with shaking at room temperature. One hundred mL of the culture was subject to centrifugation at 4;000 × g for 10 min, the pelleted cells resuspended in 10 ml of lysis buffer containing 50 mM NaH 2 PO 4 , pH 7.8, 300 mM NaCl, 10 mM imidazole, 1 mM MgCl 2 , 1 mM PMSF, 1% glycerol (v∕v), then sonicated 4 × for 10 sec with a microprobe sonicator at 60% maximum power. The samples were cooled on ice for 2 min between sonication treatments. The sonicate was centrifuged at 16;000 × g for 10 min at 4°C and the supernatant used for purification of the hexa-histidine tagged enzymes.
Purification of the bacterial expressed enzymes was afforded by the amino-terminal hexa-histidine tag using His-Select Cobalt affinity gel (Sigma) columns according the manufacturer's recommendations. Recovery of proteins with the expected molecular sizes was determined by SDS/PAGE. The purified protein fractions were concentrated using Amicon Ultra (0.5 ml, 10 K) centrifugation filter units and stored in 300 mM NaCl, 20 mM TrisHCl pH 7.5, 5 mM dithiothreitol, 2 mM MgCL 2 , 50% glycerol (v∕v) at −20°C for 2-3 weeks without noticeable loss of activity.
Typical enzyme assays were initiated by mixing aliquots of purified enzyme with 50 mM Mops, pH 7.3, 20 mM MgCl 2 , 2.5 mM 2-mercaptoethanol, 10 μM [1-3 H]-FPP (approximately 2 × 10 5 dpm total), and 2 mM NADPH in total reaction volume of 50 μl. Reactions were incubated at 37°C for 1 h and then extracted with 100 μl n-hexane or 100 μl MTBE. Forty μl of the n-hexane or MTBE extract was then spotted onto silica TLC plates with authentic standards of botryococcene and squalene and developed with n-hexane, or standards of bisfarnesyl ether and developed with n-hexane:MTBE, 25∶1. The standards were visualized with iodine vapors and TLC zones corresponding to the standards were scrapped and analyzed by scintillation spectrometry. If Botryococcus lysate was added to enzyme assays, typically 5 μl of lysate (corresponding to 10 μg total protein) prepared from B. braunii cells according to Okada et al. (1) was added. Cold assays were scaled up to 0.5 ml total volume and contained 10 μM FPP. Assays were extracted once with 1 ml n-hexane, then with 1 ml MTBE, the organic extracts pooled, and solvent evaporated under a stream of N 2 . Extracts were resuspended in 50 μl hexane and an aliquot analyzed by GC-MS with a Varian CP-3800 GC coupled to a Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused silica capillary column (30 m × 0.25 mm × 0.25 μM film thickness, Supelco). Initial oven temperature was set at 220°C for 1 min., ramped to 280°C at 1°C∕ min., then ramped to 300°C at 3°C∕ min.
For reactions requiring dephosphorylation of reaction products like PSPP, the reactions were extracted 3× with 200 μl water saturated 1-butanol and pooled in a 4 ml glass screw cap vial. The butanol was evaporated with N 2 and the white residue resuspended in 2 ml of acid phosphatase solution (20% 1-propanol (v∕v), 100 mM sodium acetate pH 4.7, 0.1% Triton X-100, 10 units sweet potato acid phosphatase) and incubated overnight (12-16 h) in a 28°C shaker. Dephosphorylated products were then extracted 3× with 1 ml n-hexane, pooled, dried with N 2 , and resuspended in 50-200 μl of n-hexane. Aliquots of the hexane extract were spotted onto reverse-phase TLC plates along with standards of FOH and PSOH and developed with methanol:acetone (8∶2). The standards were visualized with iodine vapors and the zones corresponding to FOH (rf ¼ 0.65) and PSOH (rf ¼ 0.45) were scraped and analyzed by scintillation spectroscopy.
Expression in Yeast.
A yeast line, CALI-7, developed previously for the generation of high intracellular concentrations of FPP was used for these purposes (3, 5) . One further modification was an insertional inactivation of the ERG 1 gene (6). The insertional mutation of this gene was created by introducing the TRP1 gene flanked by DNA sequences of the 5′ and 3′ region of the ERG 1 gene into the CALI-7 cells and subsequent selection for reversion of tryptophan auxotrophic growth according to the method of Wang et al. (7) . This modified yeast line capable of accumulating high levels of FPP but not metabolizing squalene is referred to as TN7.
The various recombinant yeast expression vectors were introduced into the TN7 yeast line via lithium acetate transformation, followed by selection for uracil and leucine auoxtrophic growth (3). Yeast lines were confirmed to possess the various expression vectors by colony PCR. Individual colonies of TN7 and the various TN7-transformants were subsequently grown in 25 ml of YPDE (nutrient rich) or Yeast Synthetic Drop-out medium (selection) for the indicated time at 25°C before analyzing the cultures for production of novel triterpene components. In brief, 1 ml aliquots of the culture were combined with 1 ml of acetone, vigorously mixed, and incubated at room temperature for 10 min. One mL of hexane was added and mixed vigorously for 60 sec. The mixture was then centrifuged briefly at 500 × g to separate the phases, and the organic phase removed and concentrated to dryness under a nitrogen stream. The dried extract was resuspended in 50-500 μl of n-hexane and a 1 μl aliquot analyzed by GC-MS as described above.
SSL-1 and SSL-3 Yeast Expression Constructs. Fusion constructs were created by employing an assembly PCR strategy as described by Sun et al. (8) . For creation of the SSL-1-SSL-3-fusion construct, oligonucleotide primers (5′-ccgGAATTCaaaacaatgactatgcaccaagaccacgg, EcoR1 restriction site in bold, and 5′-ACCAGAACCACCACCAGAACCACCACCAGAACCACCcttggtgggagttggggctgcgc, (GGSG)x3 linker in bold) were used with SSL-1 as the template to amplify SSL-1 with a 3′-extension, and oligonucleotide primers (5′-GGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTatgaaacttcgggaagtcttgc, (GGSG)x3 linker in bold, and 5′-ataagaatGCGGCCGCctaagcacccttagctgaaacc, NotI restriction site in bold) were used with SSL-3 as the template to amplify SSL-3 with a 5′-extension. The two PCR amplification products were purified and both used in a subsequent PCR reaction with the flanking oligonucleotide primers (5′-ccgGAATTCaaaacaatgactatgcaccaagaccacgg, EcoR1 restriction site in bold, and 5′-ataagaatGCGGCCGCctaagcacccttagctgaaacc, NotI restriction site in bold). The fused amplification product was purified, digested with EcoRI and NotI, and ligated into YEp352 (YEp352-SSL-1-3-fus). The SSL-3-SSL-1-fusion construct was created similarly (YEP352-SSL-3-1-fus), except that the oligonucleotide primers (5′-cggGAATTCaaaacaatgaaacttcgggaagtcttgcagc, EcoRI restriction site in bold, and 5′-ACCAGAACCACCACCAGAACCACCACCAGAACCACCagcacccttagctgaaacctttcc, (GGSG)x3 linker in bold) were used with SSL-3 as the template and oligonucleotide primers (5′-GGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTatgactatgcaccaaga ccacgg, (GGSG)x3 linker in bold, and 5′-ataagaatGCGGCCGCttacttggtgggagttggggctg cgc, NotI restriction site in bold) were used with SSL1 as the template.
The SSL1-BSS 63 construct was created using the same assembly PCR methodology with oligonucleotide primers (5′-cgcGGATCCaaaacaatgactatgcaccaagaccacgg, BamHI restriction site in bold, and 5′-gcgctaacaacttggtgggagttggggctgcgcagaaagatttc) with SSL-1 as the template to amplify SSL-1 with a 3′-extension, and oligonucleotide primers 5′-ctcccaccaagttgttagcgctgacgggaggcagcttctacc, and 5′-ataaagaatGCGGCCGCttaggc gctgagtgtgggtctagg, NotI site in bold) with BSS as the template to amplify the C terminus of BSS with a 5′-extension. Following completion of the assembly PCR protocol, the amplification product was digested with BamHI and NotI and ligated into pESC (pESC-SSL-1-BSS 63 ). The SSL-3-BSS 71 construct was created in the same manner except that oligonucleotide primers (5′-cggGAATTCaaaacaatgaaacttcgggaagtcttgcagc, EcoRI restriction site in bold, and 5′-cgtcaaaggtagcacccttagctgaaacctttccatttgattttg) were used with SSL-3 as the template and (5′-gctaagggtgctacctttgacgaattgaggagcaggttgttagcg, and 5′-ataaagaatGCGGCCGCttaggcgctgagtgtgggtctagg, NotI site in bold) were used with BSS as the template. The assembly PCR amplicon was ligated into YEp352 (YEP352-SSL3-BSS 71 ).
Purification of Bisfarnesyl Ether. TN7 yeast containing YEp352-SSL2 was grown in 1L YPDE media at 25°C for 8 days, after which hexane extracts were prepared. The raw yeast extracts were then subject to HPLC separation on a Waters 2695 HPLC with a Waters 2996 Photodiode Array detector (Waters Corporation) and a Develosil 60-3, 250 mm × 20 mm column (Nomura Chemical), run with an isocratic solvent (n-hexane:MTBE, 50∶1) at 8 mL∕ min. Under these conditions, bisfarnesyl ether eluted at approximately 16 min. Further purification of the bisfarnesyl ether was afforded by successive chromatographic runs.
Synthesis of (2E,6E)-3,7,11-trimethyl-1-((2E,6E)-3,7,11trimethyldodeca-2,6,10-trienyloxy)dodeca-2,6,10-triene or Bisfarnesyl Ether. To 81 mg (2.03 mmole, 2 eq) of 60% sodium hydride (washed with anhydrous hexanes to remove mineral oil) in 1 mL of anhydrous THF under an argon atmosphere at 0°C, 228 mg (1.02 mmol) of trans, trans-farnesol in 1 mL of anhydrous THF was added. The mixture was stirred for 10 min, then 438 mg (1.53 mmol, 1.5 eq) of trans, trans-farnesyl bromide was added in 0.5 ml of anhydrous THF. The mixture was stirred for 20 h and allowed to warm to 25°C. The reaction was quenched with 2 mL of 1M HCl, diluted with EtOAc, washed successively with water and brine and dried over anhydrous MgSO 4 . The crude product was chromatographed on silica gel F254 preparative TLC plates (Merck) in 1∶10 EtOAc: hexanes to afford 174 mg (40%) of bisfarnesyl ether that had NMR and mass spectral data identical to that of material produced in enzymatic reactions (Fig. S4) .
NMR of Bisfarnesyl Ether. 1 H and 13 C NMR spectra were recorded on a JEOL alpha 600 NMR spectrometer at 300K. Chemical shifts were referenced relative to solvent peaks, namely δ H 7.24 and δ C 77.00 for CDCl 3 . Results are shown in Fig. S4 . Fig. S2 . Dependence of the squalene synthase-like-1 enzyme on algal lysate for botryococcene biosynthesis. Purified SSL-1 enzyme (1 μg) (SSL-1), B. braunii 2,000 g whole-cell lysate (10 μg protein) (Lys), and equal aliquots of both SSL-1 and lysate were incubated with radiolabeled FPP, with (+) or without (−) 2 mM NADPH and the incorporation into squalene and botryococcene determined by TLC separation of the reaction products followed by scintillation counting of the corresponding zones (A). Increasing amounts of purified SSL-1 were incubated with 10 μg of B. braunii 2,000 g whole-cell lysate and the incorporation of radiolabeled FPP into squalene and botryococcene determined by TLC separation/scintillation counting (B). B. braunii 2,000 g whole-cell lysates were prepared from cells collected at the indicated times (weeks) after subculturing, and aliquots containing 10 μg of protein were incubated without (−) or with (+) 1 μg of purified SSL-1 protein, and incorporation of radiolabeled FPP into squalene and botryococcene determined (C). The SSL-1 gene containing a 5′ terminal sequence coding for a hexa-histidine tag was overexpressed in E. coli and the corresponding enzyme purified by cobalt affinity chromatography according to the manufacturer (Sigma). B. braunii lysate was prepared from cells collected at the indicated stages of culture development according to the procedure described by Okada et al. (1) and 10 μg of lysate protein was used per assay. Assays were incubated at 37°C for 1 h, then the reaction products extracted with hexane. Aliquots of the hexane extracts was separated by silica TLC and the radioactivity migrating to zones corresponding to authentic standards of botryococcene and squalene determined by scintillation counting. Data represents mean AE s:e:m. Fig. S3 . Michaelis-Menten enzyme kinetics of the SSL-1 reaction. Enzyme assays (50 μl) were set up as described in Methods with purified SSL-1 (0.2 AE 1.0 μg), 0.1% triton X-100, AE2 mM NADPH, and the indicated concentration of 3 H-FPP. Assays were incubated for 15 min at 37°C and stopped by addition of 50 μl 0.5 M EDTA. The reactions were then extracted 3× with 200 μl water saturated 1-butanol and pooled in a 4 mL glass screw cap vial. The butanol was evaporated with a stream of nitrogen gas and the white residue was resuspended in 2 ml of acid phosphatase solution (20% 1-propanol (v∕v), 100 mM sodium acetate pH 4.7, 0.1% Triton X-100, 10 units sweet potato acid phosphatase) and incubated overnight (12-16 h) in a 28°C shaker. Dephosphorylated products were extracted 3× with 1 ml n-hexane, pooled, dried with a stream of nitrogen gas, and resuspended in 200 μl of n-hexane. Aliquots of the hexane extract were spotted onto reverse-phase TLC plates along with standards of FOH and PSOH and developed with methanol:acetone (8∶2). The standards were visualized with iodine vapors and the zones corresponding to FOH (rf ¼ 0.65) and PSOH (rf ¼ 0.45) were scraped and analyzed by scintillation spectroscopy. Addition of NADPH had no significant effect on enzyme activity (less than 4% difference) and greater than 95% of the input radioactivity was recovered as FOH and PSOH, indicating that PSPP is the only dominant reaction product formed from FPP by the SSL-1 enzyme. The data was analyzed using the SigmaPlot Enzyme Kinetics 1.3 software. Data represents mean AE S:E:M of duplicate assays with and triplicate assays without NADPH. No NADPH was provided in these reactions, conditions that support PSPP formation by squalene synthase as described by Rilling (1). The assays were incubated at 37°C for 1 h, then extracted 3× with 500 μl water saturated 1-butanol, pooled, and evaporated under a stream of nitrogen gas. The white residue was resuspended in 50 μl of 25 mM NH 4 HCO 3 in 70% ethanol (v∕v). An aliquot of the resuspension was analyzed by the acid phosphatase assay (described in Fig. S3 ) and shown to consist of 45% and 40% PSPP for the SSL-1 and TSS primary incubations, respectively. The remaining reaction product (55% and 60%, respectively) in both assays was FPP. It was calculated that 1 μl of each resuspension contained approximately 150 pmoles of 3 H-PSPP. Secondary enzyme assays (50 μl) were set up with 1 μl of the reaction products isolated from the primary incubations (approximately 3 μM PSPP and approximately 4 μM FPP), 2 mM NADPH, and either 1 μg of SSL-3 or SSL-2 enzyme. For comparison, enzyme assays were also set up containing 3 μM 3 H-FPP, 2 mM NADPH and either 1 μg each of SSL-1 plus SSL-3, or SSL-1 plus SSL-2. Additional control assays contained 5 μM 3 H-FPP, 2 mM NADPH, and either 1 μg of SSL-3 or SSL-2. The reactions were incubated at 37°C for 15 min, stopped by addition of 50 μl 0.5 M EDTA, and extracted with 100 μl n-hexane. Aliquots of the hexane extracts, along with standards of squalene and botryococcene, were separated by silica TLC using n-hexane as the developing solvent. Standards were visualized with iodine vapors and the corresponding zones were analyzed by scintillation spectroscopy. Botryococcene biosynthesis is shown in blue and squalene biosynthesis is shown in red. Data represents mean AE S:E:M. Assays were performed as described above in Methods except that an alternative reaction buffer (50 mM Tris pH 8.0, 250 mM NaCl, 20 mM MgCl2) was used to minimize spontaneous NADPH oxidation and prevent protein precipitation at high concentrations. All the assays also contained 100 μM NADPH and 40 μM FPP in 300 μl final reaction volumes and the oxidation of NADPH monitored at 340 nm with a Biorad SmartSpec Plus at room temperature (23°C). An extinction coefficient of 6220/M/cm was used to calculate the amount of NADPH oxidized. No NADPH oxidation could be measured in complete reaction buffer without protein over a 1 h incubation. When either TSS or SSL-2 was incubated in reaction buffer without FPP, NADPH was oxidized at a rate of 24 and 22 pmoles∕μg protein/h, respectively, suggesting that both enzymes cause a slight oxidation of NADPH that is uncoupled with squalene or bisfarnesyl ether biosynthesis. This background NADPH oxidation was subtracted from the experimental determined rates. The experimental enzyme assays contained either purified TSS (0.75 or 1.5 μg) or SSL-2 (8 or 16 μg) and 40 μM 3 H-FPP. Absorbance at 430 nm was recorded every 2.5 min. for 15 minutes, after which the reaction was stopped by adding an equal volume of 0.5 M EDTA. The reaction mixture was collected, extracted with 200 μl of hexane and aliquots were separated by silica TLC along with standards of squalene and bisfarnesyl ether using hexane:MTBE (25∶1) as the developing solvent. The standards were subsequently visualized with iodine vapor, and corresponding zones analyzed by scintillation spectroscopy. Data represents mean AE S:E:M of duplicate samples.
